Published in Gene Therapy Weekly, March 17th, 2005
"We are pleased to formalize our relationship with OriGene. We have found their TrueClone collection to be the best answer to expanding needs within the pharmaceutical industry to access readily available full-length human cDNAs for multiple drug targets in a timely and reliable manner," said Juan Ballesteros, chief scientific officer of Novasite.
Ballesteros continued, "The OriGene TrueClone collection will complement our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.